Securities Suit Against Par Pharma Execs To Go On

Law360, New York (October 1, 2009, 3:21 PM EDT) -- A federal judge has ruled that a securities class action can continue against Par Pharmaceutical Cos. Inc.’s former chief executive officer and a former vice president, but has cleared one former head of the company from the case.

Judge Peter G. Sheridan of the U.S. District Court for the District of New Jersey on Wednesday determined that company shareholders could pursue claims that Scott Tarriff, Par’s former CEO and president until 2006, and Dennis O’Connor, the company’s former vice president, knew about or disregarded the company’s...
To view the full article, register now.